Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:AVGR NASDAQ:PTHL NASDAQ:STSS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.05-1.4%$1.36$1.03▼$21.49$5.38M-2.96629,692 shs81,677 shsAVGRAvinger$0.47$0.47$0.36▼$1.93$1.57M1.291.46 million shsN/APTHLPheton$0.55-5.2%$14.09$0.53▼$32.00$3.59MN/A857,513 shs331,732 shsSTSSSharps Technology$4.67-8.6%$5.54$3.36▼$2,145.00$4.76M2.15639,835 shs84,550 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical-5.36%-7.02%-32.91%-40.65%-91.59%AVGRAvinger0.00%0.00%0.00%0.00%-58.60%PTHLPheton-10.16%-19.57%-97.41%-89.35%+57,499,900.00%STSSSharps Technology+0.99%-5.37%-11.44%+34.12%+510,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.6141 of 5 stars3.52.00.00.01.61.71.3AVGRAvingerN/AN/AN/AN/AN/AN/AN/AN/APTHLPhetonN/AN/AN/AN/AN/AN/AN/AN/ASTSSSharps Technology2.114 of 5 stars0.05.00.00.03.71.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.501,486.54% UpsideAVGRAvinger 0.00N/AN/AN/APTHLPheton 0.00N/AN/AN/ASTSSSharps Technology 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$1.37 per shareN/AAVGRAvinger$7.65M0.21N/AN/A($4.53) per share-0.10PTHLPheton$448.20K7.86N/AN/A$0.94 per share0.57STSSSharps TechnologyN/AN/AN/AN/A$14.21 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$11.41M-$5.74N/AN/AN/AN/A-172.93%-133.39%N/AAVGRAvinger-$18.32M-$11.06N/AN/AN/AN/AN/AN/AN/APTHLPheton-$660KN/A0.00∞N/AN/AN/AN/AN/ASTSSSharps Technology-$9.30M-$1,212.34N/A∞N/AN/A-8.72%-5.30%N/ALatest AVGR, STSS, AMIX, and PTHL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q1 2026AMIXAutonomix Medical-$0.98-$1.07-$0.09-$1.07N/AN/A8/13/2025Q2 2025STSSSharps Technology-$0.94$3.58+$4.52$3.58$0.25 million$0.22 million5/29/2025Q4 2025AMIXAutonomix MedicalN/A-$0.74N/A-$0.74N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/AAVGRAvingerN/AN/AN/AN/AN/APTHLPhetonN/AN/AN/AN/AN/ASTSSSharps TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.574.57AVGRAvingerN/AN/AN/APTHLPhetonN/A12.3912.17STSSSharps TechnologyN/A4.353.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%AVGRAvinger18.30%PTHLPhetonN/ASTSSSharps Technology17.17%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%AVGRAvinger42.80%PTHLPhetonN/ASTSSSharps Technology0.15%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical15.15 million3.48 millionN/AAVGRAvinger703.31 million1.89 millionNot OptionablePTHLPheton116.58 millionN/AN/ASTSSSharps Technology31.02 million1.02 millionNot OptionableAVGR, STSS, AMIX, and PTHL HeadlinesRecent News About These CompaniesSharps Technology, Inc. (NASDAQ:STSS) Short Interest Down 70.5% in JulyAugust 18 at 4:29 AM | americanbankingnews.comSharps Technology Inc. Stock Grades | STSS | Barron'sJuly 17, 2025 | barrons.comSharps Technology Appoints Paul Danner as Executive ChairmanJuly 9, 2025 | theglobeandmail.comSharps Technology Inc. Company & People | STSS | Barron'sJune 29, 2025 | barrons.comSharps Technology Inc News (STSS) - Investing.comJune 26, 2025 | investing.comSharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility UpgradesJune 18, 2025 | globenewswire.comSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 11, 2025 | markets.businessinsider.comSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 11, 2025 | financialpost.comFSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 11, 2025 | globenewswire.comSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 10, 2025 | financialpost.comFSharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ETJune 10, 2025 | globenewswire.comSharps Technology, Inc. CEO Robert Hayes to Present at Virtual Investor Summit on June 10, 2025June 9, 2025 | quiverquant.comQSharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025June 9, 2025 | globenewswire.comSharps Technology stock soars on first commercial shipmentsJune 4, 2025 | investing.comSharps Technology Shares Rise After New Shipments BeginJune 4, 2025 | marketwatch.comSharps Technology Begins Shipping Smart Safety SyringesJune 4, 2025 | tipranks.comSharps Technology, Inc. Begins Commercial Shipments of Smart Safety Syringes, Marking Revenue Generation MilestoneJune 4, 2025 | quiverquant.comQSharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase AgreementsJune 4, 2025 | globenewswire.comSharps Technology Regains Nasdaq ComplianceMay 22, 2025 | tipranks.comSharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing RuleMay 22, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAVGR, STSS, AMIX, and PTHL Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.04 -0.02 (-1.42%) Closing price 03:59 PM EasternExtended Trading$1.04 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Avinger NASDAQ:AVGRAvinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.Pheton NASDAQ:PTHL$0.55 -0.03 (-5.22%) Closing price 03:58 PM EasternExtended Trading$0.55 0.00 (0.00%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.Sharps Technology NASDAQ:STSS$4.67 -0.44 (-8.59%) Closing price 03:58 PM EasternExtended Trading$4.94 +0.27 (+5.76%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Target: Missing the Mark in 2025—Downtrend May Continue Renaissance Hedge Fund Adds NVIDIA, Follows Buffett Into UNH Archer's Flight Milestones & Defense Wins Excite Wall Street Home Depot Holds Gains After Narrow Q2 Misses 2 Powerful Forces Now Back Intel's Turnaround The Case for Buying NVIDIA Stock Ahead of the Robotics Surge Medtronic: The Opportunity Gets Healthier for Income Investors Tesla's Breakout: Why This Rally Looks Far From Over Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access